Hygiene and wellness brand Pee Safe partially closed its Series B funding round

Pee Safe has closed a portion of its Series B round of funding. Out of the $6 million total round size, the company has disclosed that it received $3 million.

Leading pharmaceutical company Natco Pharma Limited and Rainmatter Health, with support from Nithin and Nikhil Kamath, the creators of Zerodha, led the funding. A previous investor, Alkemi Growth Capital, also took part in the round.

In June 2021, the Gurugram-based company raised its pre-Series B round, which was worth about $3 million. In a press release, Pee Safe stated that the additional funds would be used for marketing and public awareness campaigns, as well as to increase the company’s retail presence in India and abroad.

Pee Safe, a personal hygiene and fast-moving consumer goods (FMCG) brand, was introduced in 2013 by Vikas and Srijana Bagaria. Aiming to meet the needs of girls from puberty to menopause, the company has expanded its product line over the past six years to include a variety of personal hygiene categories.

It currently has a strong online presence on major e-commerce platforms and is accessible in more than 15,000 physical retail stores spread across more than 70 Indian cities. According to the company, it also exports to 20 nations across 5 continents.

The company claims to have grown at a 100% CAGR over the previous five years, despite the fact that Pee Safe has not yet submitted its FY23 results.